V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009691 | 260006208 | 1.94 | 86 | Disease modification (D) | 2018-04-21 | 2018-04-26 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 2 | N | 260008307 | EP |
| 260009692 | 260006209 | 1.78 | 97 | null | 2018-02-24 | 2018-03-03 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | null | 260008350 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009693 | 260006210 | 1.75 | 92.2 | Curative (C) | 2014-12-27 | 2014-12-27 | Cisplatin + Etoposide (5 day) | N | N | 260008373 | IVADO |
| 260009694 | 260012344 | 1.93 | 90.9 | Curative (C) | 2015-10-15 | 2015-10-23 | PEMBROLIZUMAB | N | N | 260008403 | CISPLATIN + ETOPOSIDE |
| 260009695 | 260012344 | 1.85 | 89 | Curative (C) | 2015-03-25 | 2015-03-29 | Cisplatin + Etoposide (3 day) | null | N | 260008403 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260009696 | 260006211 | 0 | 76 | Palliative (P) | null | 2019-02-10 | 111 Trial (formerly BEP 111) | N | N | 260008455 | CISPLATIN + ETOPOSIDE |
| 260009697 | 260012345 | 1.67 | 64 | Disease modification (D) | 2014-07-04 | 2014-07-10 | EP | N | N | 260008481 | TIP |
| 260009698 | 260006212 | 1.79 | 85 | Disease modification (D) | 2014-09-13 | 2014-10-19 | IVA | 2 | N | 260008525 | CISPLATIN + ETOPOSIDE |
| 260009699 | 260006213 | 1.64 | 99 | Disease modification (D) | 2016-02-22 | 2016-03-05 | IVA | 02 | N | 260008537 | EP |
| 260009700 | 260006213 | null | 73.5 | Palliative (P) | 2015-01-23 | 2015-01-29 | EP 1 2 or 3 day | N | N | 260008537 | CISPLATIN + ETOPOSIDE |
| 260009701 | 260006214 | 1.85 | 99 | Palliative (P) | null | 2016-05-27 | ETOPOSIDE | N | N | 260008561 | EP |
| 260009702 | 260006215 | 1.76 | 59 | Curative (C) | 2014-06-01 | 2014-06-18 | CISPLATIN + ETOPOSIDE | N | N | 260008571 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009703 | 260006215 | 1.72 | 90 | Palliative (P) | 2013-04-04 | 2013-05-24 | Pazopanib | 02 | N | 260008571 | CISPLATIN + ETOPOSIDE |
| 260009704 | 260006216 | 1.73 | 103.9 | Disease modification (D) | 2018-07-14 | 2018-07-23 | Cisplatin + Etoposide (3 day) | N | N | 260008586 | CISPLATIN + ETOPOSIDE |
| 260009705 | 260006216 | 1.53 | 53 | Curative (C) | 2017-04-08 | 2017-04-23 | Rituximab (Maintenance) | N | N | 260008586 | HYDROXYCARBAMIDE |
| 260009706 | 260006216 | null | 80.7 | Curative (C) | 2013-11-03 | 2013-11-10 | Trial Unspecified | 2 | Y | 260008586 | CISPLATIN + ETOPOSIDE |
| 260009707 | 260006217 | 1.76 | 71.9 | Curative (C) | 2017-12-24 | 2018-01-03 | Rituximab | 02 | N | 260008651 | RITUXIMAB |
| 260009708 | 260006218 | null | 56.6 | Palliative (P) | 2018-08-02 | 2018-08-02 | Rituximab (SUBCUTANEOUS Maintenance) | 02 | Y | 260008660 | BLEOMYCIN + VINCRISTINE |
| 260009709 | 260006218 | 1.71 | 110.4 | Disease modification (D) | 2017-12-21 | 2018-01-01 | Rituximab | N | N | 260008660 | CVP |
| 260009710 | 260006218 | null | null | Disease modification (D) | 2016-04-10 | 2016-04-12 | Carboplatin + Etoposide IV 3 day | N | N | 260008660 | NOT MATCHED |
| 260009711 | 260006218 | null | 67 | Neo-adjuvant (N) | 2016-06-05 | 2017-01-22 | Rituximab | 02 | N | 260008660 | RITUXIMAB |
| 260009712 | 260006218 | 1.69 | 63.7 | Curative (C) | 2017-06-05 | 2017-06-05 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 02 | N | 260008660 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260009713 | 260006219 | 1.67 | 67.7 | Palliative (P) | 2019-01-18 | 2019-02-06 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 260008733 | NOT MATCHED |
| 260009714 | 260006219 | null | 38.6 | null | 2018-04-11 | 2018-04-22 | Rituximab | N | N | 260008733 | RITUXIMAB |
| 260009715 | 260006220 | 1.84 | 70 | Curative (C) | 2016-01-18 | 2016-02-04 | TIP | N | N | 260008736 | CISPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260009716 | 260006220 | 1.71 | 110 | Curative (C) | 2014-02-01 | 2014-03-01 | EP | N | N | 260008736 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260009717 | 260015686 | 1.56 | 72 | Curative (C) | 2018-06-05 | 2018-06-28 | Carboplatin + Paclitaxel (3 weekly) | N | N | 260008770 | CHLORAMBUCIL |
| 260009718 | 260015686 | null | 78.3 | Palliative (P) | 2016-06-04 | 2016-06-06 | 111 Trial (formerly BEP 111) | N | N | 260008770 | CISPLATIN + ETOPOSIDE |
| 260009719 | 260015686 | null | 64 | Curative (C) | 2017-03-18 | 2017-03-18 | TIP | null | N | 260008770 | RITUXIMAB |
| 260009720 | 260006221 | null | 67 | null | 2018-04-05 | 2018-04-08 | Trial Unspecified | N | N | 260008803 | RITUXIMAB |
| 260009721 | 260012352 | null | null | Disease modification (D) | null | 2019-01-08 | Cisplatin + Etoposide (5 day) | N | N | 260008804 | TIP |
| 260009722 | 260012352 | null | null | Not known (9) | null | 2019-04-23 | Cisplatin + Docetaxel +Fluorouracil | null | null | 260008804 | CARBOPLATIN + PEMETREXED |
| 260009723 | 260012352 | 1.62 | 55.2 | Palliative (P) | 2018-04-26 | 2018-05-19 | Rituximab | N | N | 260008804 | RITUXIMAB |
| 260009724 | 260012352 | 1.74 | 84.5 | Palliative (P) | 2014-03-08 | 2014-03-11 | Cisplatin + Etoposide (3 day) | N | N | 260008804 | CISPLATIN + ETOPOSIDE |
| 260009725 | 260018897 | 0 | 56.6 | null | 2016-10-09 | 2016-10-11 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260008884 | PACLITAXEL |
| 260009726 | 260006222 | 1.71 | null | Curative (C) | 2014-09-19 | 2014-10-01 | CETUXIMAB | 02 | N | 260008889 | ETOPOSIDE |
| 260009727 | 260006223 | 1.6 | null | Palliative (P) | 2018-11-08 | 2018-11-08 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 260008894 | FEC |
| 260009728 | 260006223 | 1.66 | 72 | null | 2014-05-11 | 2014-06-02 | PACIFICO TRIAL | N | N | 260008894 | FCR |
| 260009729 | 260015688 | 1.78 | 70 | Curative (C) | 2015-06-27 | 2015-07-03 | Carboplatin + Etoposide iv&po | 2 | N | 260008930 | CISPLATIN + ETOPOSIDE |
| 260009730 | 260015688 | 1.62 | 0 | Curative (C) | 2018-04-01 | 2018-10-05 | Rituximab | Y | N | 260008930 | NOT MATCHED |
| 260009731 | 260006224 | 1.74 | 92.4 | null | 2016-09-17 | 2016-09-24 | Carboplatin + Etoposide IV 3 day | N | N | 260008975 | RITUXIMAB |
| 260009732 | 260012354 | 1.72 | 111.9 | null | 2018-09-12 | 2018-09-12 | Cisplatin + Etoposide (3 day) | 2 | N | 260009010 | CISPLATIN + ETOPOSIDE |
| 260009733 | 260006225 | 1.7 | null | Curative (C) | 2017-08-26 | 2017-09-03 | Pazopanib | N | N | 260009037 | CARBOPLATIN + ETOPOSIDE |
| 260009734 | 260006225 | null | 83.8 | Not known (9) | null | 2017-09-09 | Rituximab (Maintenance) | null | null | 260009037 | FCR |
| 260009735 | 260015689 | 1.81 | 60 | Not known (9) | 2018-08-14 | 2018-08-15 | Cisplatin + Etoposide (5 day) | 99 | null | 260009048 | CISPLATIN + ETOPOSIDE |
| 260009736 | 260015689 | 1.78 | null | Palliative (P) | 2015-04-08 | 2015-04-13 | CISPLATIN + ETOPOSIDE | null | null | 260009048 | VIP |
| 260009737 | 260006226 | 1.74 | 72.3 | Adjuvant (A) | 2015-12-08 | 2015-12-09 | Cisplatin + Etoposide (3 day) | N | N | 260009056 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 260009738 | 260006226 | 1.79 | 89 | Curative (C) | 2013-07-12 | 2013-07-25 | Cisplatin + Etoposide (5 day) | N | N | 260009056 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260009739 | 260006227 | 1.8 | 73.8 | Curative (C) | 2016-11-23 | 2016-11-23 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260009099 | CISPLATIN + ETOPOSIDE |
| 260009740 | 260006228 | 0 | 74 | Disease modification (D) | 2016-01-02 | 2016-01-09 | Cisplatin + Etoposide (3 day) | N | N | 260009128 | TIP |